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Abstract
Background: Dermoscopy, diagnostic cytology, confocal 
microscopy are used to improve diagnostic accuracy. Frozen 
section techniques have been used to control margins but not for 
diagnosis.
Objectives: We used a new frozen section technique called 
immediate cutaneous diagnosis for nonmelanoma skin cancer, 
assessing its feasibility and accuracy in obtaining a result within 15 
minutes and recording limitations.
Methods and Materials: An observational, prospective clinical 
study was designed. Biological samples were divided into two: one 
half was included in paraffin, following the standard procedure, and 
immediate cutaneous diagnosis was applied in the other. Fresh 
tissue was examined by frozen sections with perpendicular slides 
and staining with toluidine blue. Two hundred and sixty patients 
were enrolled. Results: Immediate cutaneous diagnosis-toluidine 
blue had a sensitivity of 98.7% (95%CI: 93.0-100%) and a specificity 
of 92.6% (95%CI: 87.4-96.1%) in detecting nonmelanoma skin 
cancer. Inter-rater agreement between two dermatopathologists 
using Cohen’s kappa was 0.796 (P<0.0001) in a subsample of 
101 cases. Immediate cutaneous diagnosis-toluidine blue had a 
sensitivity for squamous epithelial lesions of 78.3% (95%CI: 63.6-
89.1%) and a specificity of 98.4% (95%CI: 95.5-99.7%).
Conclusion: Immediate cutaneous diagnosis is a new, ambulatory, 
minimally invasive, rapid diagnostic technique that is ideal when 
Mohs surgery infrastructure and staff are available.
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Introduction
Nonmelanoma skin cancer is the most common cancer 
worldwide [1,2] and a wide variety of diagnostic techniques have 
been developed. Today’s society demands rapid reliable diagnosis of 
skin cancer with minimum morbidity [3]. For the last three decades, 
we have used Mohs micrographic surgery (MMS) for the removal of 
high risk skin cancers. MMS is a tissue-sparing technique for skin 
cancers with a cure rate of 99% for basal cell carcinomas (BCC) and 
97% for squamous cell carcinomas (SCC) [4].
Reports suggest the accuracy of frozen section margins of skin 
cancer in surgical treatment is around 85% versus paraffin sections 
[5,6]. Specifically, traditional frozen section examinations are 
accurate in evaluating margins for BCC in approximately 90% to 95% 
of cases [7,8]. Frozen section techniques have been used to control 
margins but not for diagnosis. Most histopathologic diagnoses 
after punch biopsy are reported after the paraffin inclusions, with a 
minimum delay of two to five days.
In everyday practice, we usually use dermoscopy, diagnostic 
cytology or other techniques to improve diagnostic accuracy and 
precision. Although punch biopsy is still the gold standard in 
the diagnosis of skin cancer, we have developed a new diagnostic 
technique to improve diagnostic accuracy. This consists of a frozen 
section technique where the biopsy result and histopathologic 
report can be obtained in 15 minutes with the same, easily available 
technical tools and staff requirements as for MMS. We have named 
this diagnostic technique immediate cutaneous diagnosis.
Objectives
●	 To verify the feasibility of immediate cutaneous diagnosis 
of nonmelanoma skin cancer in order to obtain a quick result, and to 
record the possible limitations of the technique.
●	 To assess the diagnostic accuracy of immediate cutaneous 
diagnosis in the clinical setting of MMS and obtain estimates of 
sensitivity and specificity with respect to the standard paraffin 
sections and inter-rater reliability among dermopathologists.
Methods
An observational prospective clinical study was designed. The 
study population consisted of patients of both sexes and all ages with 
skin lesions suggestive of nonmelanoma skin cancer. Two hundred 
and sixty patients were recruited by consecutive sampling from 
outpatients at the Dermatology Department.
Patients were considered for inclusion in the study if the authors 
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suspected lesions with malignancy, poorly defined clinical borders, 
or residual or relapsing tumors without prior histological diagnosis. 
Exclusion criteria were clinically evident skin lesions which were 
easily diagnosed and did not require punch biopsy for diagnosis.
All patients were informed of the study characteristics and 
provided signed informed consent. The study was approved by the 
hospital ethics committee.
The anatomic site of the lesion was recorded and classified as: face/
neck, scalp, trunk, upper and lower limbs, genitalia or oral mucosa. 
The suspected clinical diagnosis and age were collected.
Tissue was extracted by 4 millimeter punch biopsy. In exophytic 
lesions with narrow pedicle, slicing was performed. In extensive or 
deep lesions, where it was expected that the puncture would provide 
little material, small spindle removal was done.
Every specimen or biological sample was divided into two halves: 
one half was included in paraffin to serve as reference [9], and the 
other half was manipulated to give frozen sections and perform 
immediate cutaneous diagnosis, which is the index test (Figure 1).
The half manipulated using paraffin section was processed in the 
traditional manner: 1-Fix in formaldehyde at different concentrations 
/ 2-Include in paraffin / 3-Cut vertical sections to exhaust the entire 
piece / 4-Stain with hematoxylin and eosin (H&E).
The other half was examined by frozen sections with perpendicular 
slides and staining with toluidine blue. The steps of this procedure (6 
minutes) were:
95° alcohol (1 min)
Toluidine blue stain (20 sec)





Immediate cutaneous diagnosis staining with hematoxylin and 
eosin (10 minutes) was carried out as follows:










Mount in with DPX
Tissues were manipulated and processed by two trained 
histotechnicians with experience in MMS. Immediate cutaneous 
diagnosis histological preparations dyed with toluidine blue were 
blindly read in batches by one dermatopathologist who filled in 
a coded list. In 23 per cent of cases (60/260) immediate cutaneous 
diagnosis preparations also dyed with hematoxylin and eosin were 
then read in the same way, and lastly the paraffin sections were read.
For validation, four diagnoses were considered together as 
squamous epithelial lesions: actinic keratosis, squamous cell 
carcinoma, Bowen’s disease and keratoacanthoma.
A random subset of 101 biological samples was reviewed later by 
a second dermatopathologist blinded to the previous results, in order 
to determine the inter-rater reliability of the immediate cutaneous 
diagnosis test.
The sample size was determined using sample size calculation 
to estimate a single proportion using the large sample normal 
approximation. For an expected sensitivity of 0.8, a minimum sample 
of 62 patients with a diagnosis of cancer, according to the reference 
standard, was required for a two-sided 95% confidence interval 
with a precision of 0.1 [10]. The same number of patients without 
this diagnosis was required to estimate specificity. The total sample 
size was obtained assuming a 30% detection of cancer as a previous 
estimate in the biopsies performed.
The sensitivity and specificity of immediate cutaneous diagnosis 
were evaluated using contingency tables. Two-sided 95% confidence 
intervals (CI) were obtained using the Agresti-Coull method or the 
exact binomial method. The statistical significance of diagnostic 
differences in the frequency distributions of other variables such 
as the anatomic site was calculated using the Chi-square test and 
nonparametric Mann-Whitney-Wilcoxon test for continuous 
variables such as age. A P-value < 0.05 was considered significant. 
Data were recorded using Microsoft Excel. The statistical analysis was 
made using the Statistical Package for Social Sciences (SPSS) (version 
18.0) for Windows.
Results
Between 1 January 2010 and 1 December 2012, two hundred and 
sixty patients were enrolled, of whom 177 (68%) were male and 83 
(32%) female. The median age was 67 years (IQR: 55.3 to 78). The 
predominant anatomic sites were the face and neck (60.8%). The 
baseline characteristics of patients are shown in table 1.
         
Figure 1:  Immediate cutaneous diagnosis procedure. (H&E: Hematoxylin and 
Eosin stain). 
Table 1: Demographic and clinical characteristics of study patients
N=260
Sex: male / female 177 / 83
Age: median (IQR) 67 (55.3-78)
Anatomic site:
Face/ Neck 158 (60.8 %)
Trunk 47 (18.1 %)
Scalp 19 (7.3 %)
Lower limbs  16 (6.2 %)
Upper limbs  15 (5.8 %)
Oral mucosa 3 (1.2 %)
Genitalia 2 (0.8%)
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Histological findings evaluated using paraffin are summarized 
in table 2. Twenty-five different diagnoses were found, including 
no pathology/nonspecific. Ten specimens remained uncertain 
due to lost or insufficient material, and therefore the total number 
of patients finally included was two hundred and fifty. The most 
common pathologic tumor types were BCC, melanocytic nevi, actinic 
keratoses and SCC, which represented almost 70% of valid cases. Five 
histopathologic examples are shown in figures 2 to 6.
BCC was the most frequent tumor type, in 31.2% (95%CI: 25.8 - 
37.2%) of cases. Age comparison between BCC and non BCC groups 
was statistically significant (P=0.001), with a median age 8.5 years 
higher in BCC patients (Figure 7). With respect to the anatomic site, 
the face and neck were significantly more frequent than the scalp, 
trunk and others (P=0.003). BCC was clinically suspected in 136 out 
of 250 cases, but only 73 were true positives.
Fifty patients (20%, 95%CI: 15.5% - 25.4%) had squamous 
epithelial lesions. The median age in patients with squamous epithelial 
lesion was seven years higher than in patients with non squamous 
epithelial lesions (P=0.007). Three quarters of squamous epithelial 
lesions were located in the neck and face, none in the lower limbs and 
only 4% in the trunk (P=0.021 vs. other sites).
Among all patients only 31 had clinical suspicion of squamous 
epithelial lesion and 10 of these were false positive. On the other 
Table 2: Histological diagnoses using all paraffin sections applying H&E stain.
Types of tumor N=250 (%)*
Basal cell carcinoma (BCC) 78 (31.2)
Nevus 44 (17.6)
Actinic keratosis 25 (10.0)
Squamous cell carcinoma /Bowen’s disease (SCC) 25 (10.0)
Seborrheic keratosis 11 (4.4)
Adnexal benign tumors 8 (3.2)
Scar 8 (3.2)
Inflammatory lesion 8 (3.2)
No pathology / nonspecific 8 (3.2)
Nonspecific ulcer 7 (2.8)
Melanoma 5 (2.0)
Pyogenic granuloma 4 (1.6)
Others (two cases each): dermatofibroma, pseudolymphoma, 
wart, angioma, actinic damage and lichenoid dermatitis
12 (4.8)
Others (single cases): dermatofibrosarcoma protuberans, atypical 
fibroxanthoma, Merkel cell tumour, leishmania, extramammary 
Paget’s disease, lentigo and fibrotic papule
7 (2.8)
*Valid cases after excluding 7 with insufficient material and 3 with 
missing values
         
Figure 2: Paraffin with hematoxylin and eosin stain: Infiltrative basal cell 
carcinoma. The tumor cells are present as narrow strands.
         
 
Figure 3: Frozen section with toluidine blue stain: Tissue section of a basal 
cell carcinoma showing the tumor lobules.
         
Figure 4: Frozen section with hematoxylin and eosin stain: Infiltrative basal 
cell carcinoma: close-up view.
         
Figure 5: Frozen section with toluidine blue stain: low power view showing the 
small size and relative uniformity of the tumor nodules.
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hand, histological test revealed 29 false negative that have would gone 
unnoticed or misunderstood.
All patients except two underwent immediate cutaneous 
diagnosis-Toluidine blue testing, but in six patients the sample material 
was of bad quality or was not sufficient to make a reading, while the 
outcomes were doubtful in four cases. Cross-classification results 
according to these data and those obtained by paraffin section method 
are shown in table 3. Simplifying all diagnoses into three categories 
(BCC, squamous epithelial lesions and others), the accuracy index or 
proportion of true results was 90.4% [(76+36+104)/239=0.904].
The results of the use of immediate cutaneous diagnosis in 
detecting BCC are presented in a flow diagram (Figure 8). Ninety-
two test results were positive for BCC, 156 were found to be other 
pathologies and 10 were inconclusive due to doubts or problems 
with the material. The gold-standard results confirmed 78 true cases 
of BCC (Table 4a). Considering only the conclusive results obtained 
by the two methods (239), the estimated sensitivity of the immediate 
cutaneous diagnosis in detecting BCC was 98.7% (95%CI: 93.0 - 
100%). Of the 162 cases without BCC, only 12 test results were positive 
giving an estimated specificity of 92.6% (95%CI: 87.4 - 96.1%).
Immediate cutaneous diagnosis showed 39 positive results for 
squamous epithelial lesions (15 actinic keratosis; 20 squamous cell 
carcinoma /Bowen’s disease and 4 keratoacanthoma) but three of these 
were false (Table 4b), and therefore the estimated sensitivity was 78.3% 
(95%CI: 63.6 - 89.1%). There were 200 negative results, but 10 were false, 
giving an estimated specificity of 98.4 (95%CI: 95.5 - 99.7%).
Immediate cutaneous diagnosis with H&E stain was used in 150 
patients (58%). After checking these results against the gold-standard, as 
done for immediate cutaneous diagnosis- Toluidine blue, the proportion 
of true results was 95.9% [(46+23+70)/145=0.959]. The estimated 
sensitivity of immediate cutaneous diagnosis-H&E was 100% (95%CI: 
92.3-100%) in diagnosing BCC and 92% (95%CI: 74-99%) in diagnosing 
squamous epithelial lesions. The estimated specificity was 96% (95%CI: 
90.0 - 98.9%) and 100% (95%CI: 97.0 - 100%) for BCC and squamous 
epithelial lesions respectively (Table 5).
Inter-rater reliability was assessed in a subsample of 101 
         
Figure 6: Frozen section with blue toloudine stain shows multiple small ductal 
structure typical of benigne syringoma.
         
Figure 7: Age comparison with respect to basal cell carcinoma.
         
Figure 8: Flow diagram for diagnostic accuracy of immediate cutaneous 
diagnosis-toluidin blue stain as in STARD initiative.
Table 3: Results of immediate cutaneous diagnosis-Toluidine blue (ICD-TB) 
against gold-standard with H&E. SEL: squamous epithelial lesions. 
All paraffin sections
BCC SEL Others Not available Total
ICD-TB BCC 76 3 9 4 92
SEL 0 36 3 0 39
Others 1 7 104 5 117
Indeterminate 1 2 1 0 4
Bad or insufficient material 0 0 5 1 6
Excluded 0 2 0 0 2
Total 78 50 122 10 260
Table 4: Validation of immediate cutaneous diagnosis-Toluidine blue (ICD-TB) 








Yes No Total ICD-TB
Results
Yes No Total
BCC+ 76 12 88 SEL+ 36 3 39
BCC- 1 150 151 SEL- 10 190 200
Total 77 162 239 Total 46 193 239
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patients. Comparison of the diagnoses between two dermatologists 
using immediate cutaneous diagnosis resulted in 20 disagreements. 
Subsequently, only two categories were considered: BCC present (+) 
or BCC absent (-). Cohen’s kappa used as a measure of concordance 
to detect BCC was 0.796 (P<0.0001). Nine non-coincident cases were 
evenly distributed in the two cells. When BCC and squamous epithelial 
lesions were joined as a single category named nonmelanoma 
epithelial carcinoma, Cohen’s kappa was 0.799 (P<0.0001). Again, the 
10 non-coincident cases were equally distributed.
Discussion
Immediate cutaneous diagnosis could represent a new approach 
to diagnosis in dermatology. The results of this study suggest that 
evaluation with frozen sections has a high concordance rate with 
permanent pathologic evaluation, with an average false negative rate 
for the entire group of 19%, which is in the range of previous reports 
[5,6,8].
In our study, immediate cutaneous diagnosis test was useful in 
ruling out BCC vs. doubtful intra-dermal facial nevus and other skin 
neoplasms. We also found statistically sensitive differences in the 
diagnosis of two groups: BCC vs. SCC, and actinic keratosis vs. SCC, 
and for the evaluation of different histopathologic patterns of BCC.
Our results verify the feasibility of the immediate cutaneous 
diagnosis in the rapid diagnosis of nonmelanoma skin cancer. The 
estimated sensitivities and specificities provide strong evidence of 
accuracy of the test.
Although punch biopsy remains the gold standard in the 
diagnosis of skin cancer, immediate cutaneous diagnostic may 
improve diagnostic accuracy and save time and money. Our study 
showed evidence of good internal/external validity and excellent 
external reliability. Further studies will be necessary to confirm our 
results and contrast them with other techniques.
The advantages of immediate cutaneous diagnosis are that 
it allows the choice of the best treatment option in each tumor 
and surgical margins and the possibility of using topical/external 
treatment in superficial BCC or actinic keratoses, when required.
Although specificity depends on material quality, the immediate 
cutaneous diagnosis provides an early diagnosis that helps until a 
result is obtained by the standard paraffin test. Toluidine blue stain 
was used in all cases because of its easy availability and its effectiveness 
in MMS.
Additionally, immediate cutaneous diagnosis reduces diagnostic 
delay to 15 minutes avoiding patient uncertainty and anxiety.
Evaluation of the costs generated by empiric treatments, 
histopathologic reports and confirmation biopsies suggests it might 
be more cost-effective to adapt histological dying techniques and 
make them accessible to dermatologists, as we suggest with immediate 
cutaneous diagnosis, as most skin biopsies can be evaluated by an 
experienced dermopathologist. Initial additional costs would soon be 
compensated by savings in the number of visits, empiric treatments 
and administrative processes.
Immediate cutaneous diagnosis is ideal for dermatology 
departments where MMS infrastructure and staff are available, 
helping to improve its profitability.
The possible disadvantages of immediate cutaneous diagnosis 
include the need for specific material and qualified staff experienced 
in MMS, the availability of MMS infrastructure and an expert 
dermatopathologist. Likewise, only half of the sample obtained was 
processed in frozen section, which could lead to some false negatives. 
In addition, a 4mm punch is only a parcel of possible tumor. Studies 
have shown that biopsies of a skin cancer are not always indicative of 
the entire tumor [11,12]. Thus, it is essential to select the ideal biopsy 
site. We doubt whether immediate cutaneous diagnosis would be 
suitable for frozen tissue specimens in the diagnosis of melanocytic 
lesions, such as malignant lentigo melanoma or malignant 
melanoma. Frozen sections of malignant melanoma and atypical 
melanocytic skin lesions are controversial [13]. The depth of invasion 
and degree of cytological atypia cannot be interpreted accurately 
using frozen section. Additionally, the section may be distorted by 
the physical process of freezing, and therefore the lesion cannot 
be accurately measured in the permanent sections. We performed 
immediate cutaneous diagnosis for evaluation in eight patients with 
inflammatory disease, but its role in inflammatory patterns will be 
analyzed in a future report.
The immediate cutaneous diagnosis allows one quickly first 
step to know with precision the tumor we have dealing in order to 
perform an immediate treatment. Only in some difficult tumors 
like Merkel carcinoma, angiosarcoma, adnexial tumors and also 
to check for perivascular or perineural involvement, we need the 
histopathology in paraffin and immunochemistry in order to obtain 
the right diagnosis.
Immediate cutaneous diagnosis could open new diagnostic 
possibilities in inflammatory and tumoral pathologies. Nowadays, 
cytology evaluation is useful for herpetic lesions, pustulosis or 
leishmaniasis, although most histopathologic reports are delayed 
due to fixation, slide reading or paperwork. Immediate cutaneous 
diagnosis could represent a standard in outpatient clinics, and could 
allow dermatologists to read slides immediately, improving clinic-
pathological correlation.
The more we simplify diagnostic techniques, such as frozen section 
samples, the easier it will be for dermatologists or dermatopathologists 
to make a diagnosis in daily practice in conjunction with clinical 
information, dermoscopy, confocal microscopy and new rapid and 
easy techniques such as immediate cutaneous diagnosis.
Although immediate cutaneous diagnosis is only used for tumoral 
pathology, the procedure could be improved to make possible an 
immediate diagnosis in outpatient’s clinics.
In conclusion, immediate cutaneous diagnosis is a new, 
ambulatory, minimally invasive, rapid diagnostic technique that is 
ideal when Mohs surgery infrastructure and staff are available and 
could aid clinical diagnosis and open new possibilities in clinical 
practice.
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